Sana Biotechnology, Inc.
SANANasdaqCIK 1770121HealthcareFiscal year ends Dec 31
Reports and events: 99 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0812:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-384405 |
| 2026-08-1020:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342395 |
| 2026-08-1020:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342371 |
| 2026-06-0520:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-259532 |
| 2026-05-1520:06 ET | 8-K | 8.01 Other events | 0001193125-26-226674 |
| 2026-05-1120:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-216769 |
| 2026-05-1120:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216758 |
| 2026-04-2410:20 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001193125-26-174883 |
| 2026-04-2410:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-174531 |
| 2026-04-1320:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-152868 |
| 2026-03-0321:14 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-088215 |
| 2026-03-0321:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-088203 |
| 2026-02-1714:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-053294 |
| 2026-01-1417:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-012664 |
| 2025-11-0621:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269569 |
| 2025-11-0621:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269522 |
| 2025-09-0510:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-25-196414 |
| 2025-08-2920:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-192766 |
| 2025-08-1120:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001770121-25-000010 |
| 2025-08-1120:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770121-25-000009 |
| 2025-08-0721:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-175571 |
| 2025-08-0620:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001193125-25-174506 |
| 2025-06-2314:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088752 |
| 2025-06-0620:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-083044 |
| 2025-05-0820:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066943 |
| 2025-05-0820:08 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-066933 |
| 2025-04-2510:08 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001193125-25-094656 |
| 2025-03-1720:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040254 |
| 2025-03-1720:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-040241 |
| 2025-01-1314:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005047 |
| 2024-11-0814:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123730 |
| 2024-11-0814:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123727 |
| 2024-10-0820:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-113524 |
| 2024-09-1220:36 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-218049 |
| 2024-08-0820:21 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094052 |
| 2024-08-0820:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093976 |
| 2024-06-0720:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-070603 |
| 2024-05-0820:21 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055727 |
| 2024-05-0820:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055673 |
| 2024-04-2610:11 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001193125-24-115454 |
| 2024-04-1821:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-100902 |
| 2024-02-2921:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023119 |
| 2024-02-2921:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023083 |
| 2024-02-0822:20 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-028506 |
| 2024-02-0721:12 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-026692 |
| 2024-01-0914:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-004910 |
| 2023-12-1121:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-292542 |
| 2023-11-0821:24 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061171 |
| 2023-11-0821:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061130 |
| 2023-10-1020:21 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-253493 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.